Jieqiong Liu
机构：Sun Yat-sen University, Sun Yat-sen Memorial Hospital · ORCID：0000-0001-7859-3764
发表论文 115 篇 · 总被引 2460 次 · h-index 27
代表论文
- First-in-human study of JSKN016, a bispecific anti-TROP2/HER3 antibody drug conjugate (ADC): Antitumor activity in patients (pts) with metastatic triple-negative breast cancer (mTNBC) and safety results. (2025 · Journal of Clinical Oncology · 被引 9)
- Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial (2025 · The Lancet Oncology · 被引 8)
- Narrative review on efficacy and safety of anti-angiogenesis in combination with immunotherapy in the treatment of breast cancer (2024 · Translational Breast Cancer Research · 被引 7)
- Evaluation of the safety, pharmacokinetics, and efficacy of JSKN003 in patients with advanced solid tumors: A phase I/II clinical study. (2024 · Journal of Clinical Oncology · 被引 7)
- Safety and Efficacy of KN046 in Combination with KN026 in Patients with Advanced HER2-Positive Breast Cancer: A Phase II Trial (2025 · Clinical Cancer Research · 被引 5)
- Relationship Between MUC4 Variants and Metastatic Recurrence in Colorectal Cancer (2023 · International Journal of General Medicine · 被引 5)